Cargando…

Prognostic Factors and Survival of Chinese Patients with Cardiac Amyloidosis

PURPOSE: To identify the survival and prognostic factors for cardiac amyloidosis (CA) in Chinese patients. METHODS: This was a prospective cohort study of 72 patients diagnosed with CA and admitted to the PLA General Hospital between November 2017 and April 2021. Demographic, clinical, laboratory, e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lu, Li, Sulei, Liu, Bohan, Wang, Jing, Mu, Yang, Zhou, Xuan, Liu, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205418/ https://www.ncbi.nlm.nih.gov/pubmed/37228893 http://dx.doi.org/10.1155/2023/3070017

Ejemplares similares

Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
por: Fagot, Jerome, et al.
Publicado: (2020)

Hemodynamic Profiles and Their Prognostic Relevance in Cardiac Amyloidosis
por: Duca, Franz, et al.
Publicado: (2020)

Diagnostic and prognostic value of cardiac imaging in amyloidosis
por: Vidal-Perez, Rafael, et al.
Publicado: (2020)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis
por: Zhang, Yang, et al.
Publicado: (2021)

Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis
por: Binder, Christina, et al.
Publicado: (2020)

Prognostic value of high-sensitivity cardiac troponin T in patients with endomyocardial-biopsy proven cardiac amyloidosis
por: Qian, Geng, et al.
Publicado: (2014)

MAGE genes: Prognostic indicators in AL amyloidosis patients
por: Liu, Yang, et al.
Publicado: (2019)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
por: Miao, Fujia, et al.
Publicado: (2023)

High Serum Lactate Dehydrogenase adds Prognostic Value to Cardiac Biomarker Staging System for Light Chain Amyloidosis
por: He, Haiyan, et al.
Publicado: (2019)

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement
por: Li, Yang, et al.
Publicado: (2021)

Hepatocyte Growth Factor and Cardiac Amyloidosis
por: Ruberg, Frederick L., et al.
Publicado: (2020)

Hereditary Transthyretin Amyloidosis in Eight Chinese Families
por: Meng, Ling-Chao, et al.
Publicado: (2015)

Cardiac Amyloidosis
por: Elbdri, Salah, et al.
Publicado: (2021)

Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis
por: Banydeen, Rishika, et al.
Publicado: (2022)

Fibrinogen A Alpha-Chain Amyloidosis in Two Chinese Patients
por: Li, Zhen-Yu, et al.
Publicado: (2022)

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis
por: Kim, Darae, et al.
Publicado: (2020)

Advance of echocardiography in cardiac amyloidosis
por: Liang, Shichu, et al.
Publicado: (2023)

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis
por: Gustine, Joshua N., et al.
Publicado: (2023)

The major factor of left ventricular systolic dysfunction in patients with cardiac amyloidosis: Amyloid overload or microcirculation impairment?
por: Lu, Jianyao, et al.
Publicado: (2023)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Delayed hyper-enhancement cardiac magnetic resonance provides incremental prognostic value in patients with cardiac amyloidosis
por: Austin, Bethany A, et al.
Publicado: (2009)

Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac Amyloidosis
por: Nakamura, Makiko, et al.
Publicado: (2023)

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging
por: Kastritis, E, et al.
Publicado: (2015)

An echo score raises the suspicion of cardiac amyloidosis in Chinese with heart failure with preserved ejection fraction
por: Yang, Hong, et al.
Publicado: (2022)

Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value
por: Cipriani, Alberto, et al.
Publicado: (2022)

Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis
por: Zampiccoli, Emanuel, et al.
Publicado: (2022)

Catastrophic Cardiac Amyloidosis
por: Panduranga, Prashanth, et al.
Publicado: (2010)

Occult cardiac amyloidosis?
por: Westin, Oscar, et al.
Publicado: (2019)

Arrhythmias in Cardiac Amyloidosis
por: John, Roy M.
Publicado: (2018)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Fulminant cardiac amyloidosis
por: Real, Carlos, et al.
Publicado: (2021)

Cardiac Amyloidosis Treatment
por: Stern, Lily K., et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma
por: Ren, Tong, et al.
Publicado: (2017)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2021)

Approach to a patient with cardiac amyloidosis
por: Strouse, Christopher, et al.
Publicado: (2019)

Gateway and journey of patients with cardiac amyloidosis
por: Dang, Daniel, et al.
Publicado: (2020)

Predictive Value of Assessing Diastolic Strain Rate on Survival in Cardiac Amyloidosis Patients with Preserved Ejection Fraction
por: Liu, Dan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ncoimdbqhpoar52o1nqrm1rv0j